| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |